BERANDA RESMI
ARC Institute
← Katalog Appraisal
TAPublishedBlood and immune system conditions / Blood and bone marrow cancers· 2025-07-23
TA1084

Idecabtagene vicleucel for treating relapsed or refractory multiple myeloma after 2 to 4 treatments (terminated appraisal)

0 item

Rekomendasi numbered